A Study Of Senyo Health With Comorbid Alcohol Use Disorder Treatment In Bipolar Disorder

Overview

About this study

The purpose of this study is to examine the effectiveness of a digital IBH platform in improving substance use outcomes, including treatment retention and substance use frequency and severity in patients with BD.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age>=18 years;

  • EHR clinical diagnosis of bipolar I disorder, bipolar II disorder, or schizoaffective disorder bipolar type

  • Ability to read, write, and understand English

  • Minimum DAST (1+) or audit-C score (3+)

  • Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care

  • Eligibility determined by ASAM Assessment

Exclusion Criteria: 

  • Inability to provide written informed consent.

  • Inability to understand English.

  • Clinically unstable medical disease.

  • Otherwise excluded for administrative reasons and/or clinician judgment.

  • Needing a higher level of mental health care as demonstrated by ASAM[36] assessment; – completed by LADC or MD investigators

  • Already admitted into or about to initiate treatment in another addiction treatment program.

  • Currently attending High School.

  • Pregnancy confirmed by self-report

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 05/18/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mark Frye, M.D.

Open for enrollment

Contact information:

Ivan Ayala

5075383987

ayala.ivan@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597425

Mayo Clinic Footer